Ugrás a tartalomhoz

abiraterone

A Wikiszótárból, a nyitott szótárból
abiraterone
Clinical data
Pronunciationa" bir a' ter one
Trade namesZytiga, Yonsa, others
Other namesCB-7630; JNJ-212082; 17-(3-Pyridinyl)androsta-5,16-dien-3β-ol acetate, abiraterone (BAN UK), abiraterone acetate (JAN JP), abiraterone acetate (USAN US)
AHFS/Drugs.comMonograph
MedlinePlusa611046
License data
Pregnancy
category
  • AU: D
Routes of
administration
By mouth
Drug classAntineoplastic
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
  • CA: ℞-only
  • UK: POM (Prescription only)
  • US: ℞-only
  • EU: Rx-only
  • In general: ℞ (Prescription only)
Pharmacokinetic data
BioavailabilityUnknown, but may be 50% at most on empty stomach
Protein bindingAbiraterone: ~99.8% (to albumin and α1-AGp)
MetabolismEsterases, CYP3A4, SULT2A1
MetabolitesAbiraterone, others
Elimination half-lifeAbiraterone: 12–24 hours
ExcretionFeces: 88%
Urine: 5%
Identifiers
  • [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
FormulaC26H33NO2
Molar mass391.555 g·mol−1
3D model (JSmol)
Melting point144 to 145 °C (291 to 293 °F)
  • CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC=C4C5=CN=CC=C5)C)C
  • InChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1
  • Key:UVIQSJCZCSLXRZ-UBUQANBQSA-N
  (verify)


Főnév

abiraterone (tsz. abiraterones)

  1. (gyógyszertan) abirateron